Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI

Mesenchymal stem cells (MSCs) are emerging as an attractive approach for restorative medicine in central nervous system (CNS) diseases and injuries, such as traumatic brain injury (TBI), due to their relatively easy derivation and therapeutic effect following transplantation. However, the long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahror, Rami Ahmad, Wu, Chung-Che, Chiang, Yung-Hsiao, Chen, Kai-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312789/
https://www.ncbi.nlm.nih.gov/pubmed/32516998
http://dx.doi.org/10.3390/ijms21114051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312789/
https://www.ncbi.nlm.nih.gov/pubmed/32516998
http://dx.doi.org/10.3390/ijms21114051

Ejemplares similares